Reaction
Cerebellar Infarction reporting signals
As of the last recalculation, Cerebellar Infarction appears in 1,667 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is FEBUXOSTAT TABLETS 40 MG (PRR 17.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Febuxostat Tablets 40 Mg | 14 | 17.3 | 17.3 |
| Febuxostat Tablets 80 Mg | 14 | 17.3 | 17.3 |
| Norepinephrine | 14 | 16.5 | 16.5 |
| Prasugrel Hydrochloride | 11 | 13.6 | 13.6 |
| Norepinephrine Bitartrate | 15 | 13.1 | 13.1 |
| Drospirenone And Ethinyl Estradiol | 38 | 11.0 | 11.0 |
| Febuxostat | 14 | 10.5 | 10.5 |
| Ranibizumab | 21 | 10.0 | 10.0 |
| Axicabtagene Ciloleucel | 7 | 8.9 | 8.9 |
| Losartan Potassium And Hydrochlorothiazide | 8 | 8.6 | 8.6 |
| Pitavastatin Calcium | 7 | 8.6 | 8.6 |
| Tranexamic Acid | 6 | 8.5 | 8.5 |
| Alteplase | 10 | 8.4 | 8.4 |
| Tobramycin Solution | 8 | 8.4 | 8.4 |
| Tobramycin Sulfate | 8 | 8.1 | 8.1 |
| Pyrazinamide | 6 | 8.0 | 8.0 |
| Etonogestrel And Ethinyl Estradiol | 14 | 7.9 | 7.9 |
| Meropenem | 20 | 7.9 | 7.9 |
| Baricitinib | 6 | 7.8 | 7.8 |
| Testosterone Cypionate | 5 | 7.0 | 7.0 |
| Rivaroxaban | 109 | 6.9 | 6.9 |
| Dabigatran Etexilate | 41 | 6.7 | 6.7 |
| Bupivacaine | 5 | 6.7 | 6.7 |
| Dabigatran Etexilate Mesylate | 37 | 6.5 | 6.5 |
| Methadone Hydrochloride | 5 | 5.8 | 5.8 |
| Brinzolamide | 4 | 5.8 | 5.8 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 4 | 5.0 | 5.0 |
| Ethyl Alcohol | 10 | 4.6 | 4.6 |
| Gefitinib | 3 | 4.2 | 4.2 |
| Agalsidase Beta | 3 | 4.1 | 4.1 |
| Alcohol | 11 | 3.6 | 3.6 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 3.4 | 3.4 |
| Erenumab-Aooe | 10 | 2.3 | 2.3 |